Radiotherapy plus Long-term Adjuvant Androgen Deprivation with a Luteinizing Hormone–releasing Hormone Antagonist Versus Agonist in Patients with Very High-risk Localized or Locally Advanced Prostate Cancer: The EORTC GUCG-1414 Phase 3 Randomized Trial

Zilli, T., Böhmer, D., Roeder, A., Lauffer, D., Villafranca Iturre, A. E., Teixidó, J. J., Supiot, S., Latorzeff, I., Dirix, P., Otte, F.-X., Francolini, G., Roumeguère, T., Simon, J. M., Fournier, B., Fortpied, C., Lara, P. C., & Tombal, B. (2025). Radiotherapy plus Long-term Adjuvant Androgen Deprivation with a Luteinizing Hormone–releasing Hormone Antagonist Versus Agonist in Patients with Very High-risk Localized or Locally Advanced Prostate Cancer: The EORTC GUCG-1414 Phase 3 Randomized Trial. European Urology Oncology, 8(6), 1639-1647. https://doi.org/10.1016/j.euo.2025.10.009 (Original work published 2025)